Islelizumab-jsgr

Generic Name: islelizumab-jsgr

Prescription Required

Manufactured by BEIGENE. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: islelizumab-jsgr (10 mg/mL). Application: BLA761380.

Overview

Manufactured by BEIGENE. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: islelizumab-jsgr (10 mg/mL). Application: BLA761380.

Dosage

Available as injectable for injection use.

Related Medications

Aloe - Aluminum Oxide - Bryonia Alba Root - Chelidonium Majus - Cholecalciferol - Collinsonia - Frangula Alnus Bark - Niacin - Pantothenic Acid - Potassium Carbonate - Rhubarb - Silybum Marianum Seed - Skatole - Sodium Carbonate - Strychnos Nux-vomica Seed - Sus Scrofa Colon - Sus Scrofa Rectum - Taraxacum Officinale - Thiamine -

aloe - aluminum oxide - bryonia alba root - chelidonium majus - cholecalciferol - collinsonia - frangula alnus bark - niacin - pantothenic acid - potassium carbonate - rhubarb - silybum marianum seed - skatole - sodium carbonate - strychnos nux-vomica seed - sus scrofa colon - sus scrofa rectum - taraxacum officinale - thiamine -

Vitamin D [EPC]

USES Temporary relief of symptoms due to constipation: Abdominal bloating Abdominal discomfort Irregularity of bowel movements

Butalbital, Acetaminophen, Caffeine And Codeine Phosphate

butalbital, acetaminophen, caffeine and codeine phosphate

Barbiturate [EPC]

11 DESCRIPTION Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are supplied in capsule form for oral administration. Each capsule contains: Butalbital, USP 50 mg Acetaminophen, USP 325 mg Caffeine, USP 40 mg Codeine phosphate, USP 30 mg Butalbital (5-allyl-5-isobutylbarbituric acid), is a short-to intermediate-acting barbiturate.

Homosalate, Octocrylene, Avobenzone

homosalate, octocrylene, avobenzone

Purpose Sunscreen

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.